XPONANCE, INC. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$23,344
-29.3%
26,348
+24.1%
0.00%
-100.0%
Q3 2022$33,000
-19.5%
21,233
+4.7%
0.00%0.0%
Q2 2022$41,000
+24.2%
20,288
+42.9%
0.00%0.0%
Q1 2022$33,000
-49.2%
14,200
+0.8%
0.00%0.0%
Q4 2021$65,000
-35.0%
14,083
+7.8%
0.00%
-50.0%
Q3 2021$100,000
-31.0%
13,068
-12.4%
0.00%
-33.3%
Q2 2021$145,00014,9250.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Paloma Partners Management Co 3,775,000$1,359,0000.05%
Oaktree Fund Advisors, LLC 66,000$23,7600.02%
GoalVest Advisory LLC 32,915$11,8490.01%
Houlihan Financial Resource Group, Ltd. 30,000$110.01%
Granite Bay Wealth Management, LLC 22,520$80.01%
S&T BANK/PA 38,853$140.00%
Lattice Capital Management, LLC 51,800$18,6480.00%
Modus Advisors, LLC 19,706$7,0940.00%
Crescent Grove Advisors, LLC 60,000$21,6000.00%
SlateStone Wealth, LLC 21,433$80.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders